Cargando…

Predicting Colorectal Cancer Occurrence in IBD

SIMPLE SUMMARY: Patients with inflammatory bowel disease are at an increased risk of developing colorectal cancer, and so are enrolled in a surveillance colonoscopy programme aimed at detecting and treating any signs of early cancer. This review describes the current known risk factors associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yalchin, Mehmet, Baker, Ann-Marie, Graham, Trevor A., Hart, Ailsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230430/ https://www.ncbi.nlm.nih.gov/pubmed/34200768 http://dx.doi.org/10.3390/cancers13122908

Ejemplares similares

Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand?
por: Al Bakir, Ibrahim, et al.
Publicado: (2022)

A blood-based prognostic biomarker in IBD
por: Biasci, Daniele, et al.
Publicado: (2019)

COVID-19: Colorectal cancer endoscopic surveillance in IBD
por: Din, Shahida, et al.
Publicado: (2021)

The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms
por: Frigerio, Sofía, et al.
Publicado: (2021)

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)

MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer
por: James, Jaslin P., et al.
Publicado: (2020)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A Review
por: Sałaga, Maciej, et al.
Publicado: (2014)

IBD metabonomics predicts phenotype, disease course, and treatment response
por: Bjerrum, Jacob T., et al.
Publicado: (2021)

Pathophysiology of IBD associated diarrhea
por: Anbazhagan, Arivarasu N., et al.
Publicado: (2018)

How to Evaluate Fibrosis in IBD?
por: Tavares de Sousa, Helena, et al.
Publicado: (2023)

Endoscopy in IBD: When and How?
por: Daperno, Marco
Publicado: (2023)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey
por: Rubin, David T, et al.
Publicado: (2021)

Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool
por: Curtius, Kit, et al.
Publicado: (2022)

Overcoming challenges in IBD management
por: Ramakrishna, B.S.
Publicado: (2015)

Impact of Diet on Risk of IBD
por: Ananthakrishnan, Ashwin N
Publicado: (2020)

Gut Serpinome: Emerging Evidence in IBD
por: Mkaouar, Héla, et al.
Publicado: (2021)

Etiology of IBD—Is It Still a Mystery?
por: Kofla-Dłubacz, Anna, et al.
Publicado: (2022)

Biomarkers in IBD: What to Utilize for the Diagnosis?
por: D’Incà, Renata, et al.
Publicado: (2023)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Tumour Cell Heterogeneity
por: Gay, Laura, et al.
Publicado: (2016)

Characterization of LGR5 stem cells in colorectal adenomas and carcinomas
por: Baker, Ann-Marie, et al.
Publicado: (2015)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Clinical importance of IL-22 cascade in IBD
por: Mizoguchi, Atsushi, et al.
Publicado: (2017)

Implications of the Westernized Diet in the Onset and Progression of IBD
por: Rizzello, Fernando, et al.
Publicado: (2019)

Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
por: Tindemans, Irma, et al.
Publicado: (2020)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

The Role of Dietary Fibers in the Management of IBD Symptoms
por: Di Rosa, Claudia, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
por: Fiocchi, Claudio
Publicado: (2023)

First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer
por: Haughey, Magnus J., et al.
Publicado: (2023)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Singh, Arshdeep, et al.
Publicado: (2023)

Factors Predicting the Adherence to the Therapy of Italian IBD Patients
por: Bucci, Cristina, et al.
Publicado: (2017)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

A predictive model of metachronous colorectal cancer occurrence in Lynch syndrome
por: Bertario, Lucio, et al.
Publicado: (2010)

Prediction of IBD based on population history for fine gene mapping
por: Hernández-Sánchez, Jules, et al.
Publicado: (2006)

New Insights into the Role of Trace Elements in IBD
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2018)

Intestinal Immune Imbalance is an Alarm in the Development of IBD
por: Hu, Chunli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0759pivebegjj208svkfv8jjnl